Bank Of America Corp Kaleido Biosciences, Inc. Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.3 - $2.7 $9,210 - $19,129
-7,085 Reduced 30.39%
16,228 $27,000
Q4 2021

Feb 08, 2022
SELL
$2.39 - $6.02 $8,541 - $21,515
-3,574 Reduced 13.29%
23,313 $56,000
Q3 2021

Nov 15, 2021
BUY
$5.36 - $7.99 $65,027 - $96,934
12,132 Added 82.22%
26,887 $147,000
Q2 2021

Sep 13, 2021
BUY
$5.82 - $8.72 $85,874 - $128,663
14,755 New
14,755 $110,000

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email